Scarica l'app Stockscreener
5.54
4.33%
0.23
Pre-mercato:
5.62
0.08
+1.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLS Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.31
Aprire:
$5.44
Volume 24 ore:
6.81M
Relative Volume:
0.81
Capitalizzazione di mercato:
$943.36M
Reddito:
-
Utile/perdita netta:
$-37.34M
Rapporto P/E:
-4.0735
EPS:
-1.36
Flusso di cassa netto:
$-36.91M
1 W Prestazione:
+21.76%
1M Prestazione:
+45.03%
6M Prestazione:
+211.24%
1 anno Prestazione:
+369.49%
Intervallo 1D:
$5.31
$5.655
Intervallo di 1 settimana:
$4.43
$5.655
Portata 52W:
$0.9516
$5.655
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Nome
Sellas Life Sciences Group Inc
Settore
Industria
Telefono
(646) 200-5278
Indirizzo
7 TIMES SQUARE, NEW YORK, NY
Compare SLS vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
5.54 | 904.20M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Iniziato | Oppenheimer | Outperform |
| 2018-04-02 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-19 | Aggiornamento | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Borsa (SLS) Ultime notizie
SELLAS Life Sciences (SLS) Is Up 21.8% After REGAL Trial Clears Key Continuation ReviewWhat's Changed - simplywall.st
SLS Stock’s Red-Hot Streak Draws Rising Short Bets — Retail Traders Are Now Betting On A Big Pharma Buyout - Stocktwits
Wall Street Recap: Can SELLAS Life Sciences Group Inc beat the S P 500July 2025 Sentiment & Safe Entry Trade Signal Reports - baoquankhu1.vn
SLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upside - Stocktwits
What's Going With SELLAS Life Sciences Stock On Wednesday? - Bitget
Bull Run: Will SELLAS Life Sciences Group Inc benefit from green energy policiesWeekly Market Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
SLS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SELLAS Life Sciences Group (NASDAQ:SLS) Hits New 12-Month HighTime to Buy? - MarketBeat
SLS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SLS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
SLS Technical Analysis & Stock Price Forecast - Intellectia AI
Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN
Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% - Asianet Newsable
SELLAS Life Sciences Group Target of Unusually Large Options Trading (NASDAQ:SLS) - MarketBeat
Stock Surge: Solstice Minerals Breakthrough at Nanadie Adventure - timothysykes.com
Why SLS stock is jumping premarket: SELLAS Life Sciences puts REGAL Phase 3 countdown back in play - Bez Kabli
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 9.8%Here's Why - MarketBeat
Solstice Minerals Shares Surge 56% on Successful Drilling Results - StocksToTrade
Anson group discloses 4.9% SELLAS Life Sciences (SLS) stake via 13G/A - Stock Titan
Profit Review: What is the target price for Green Dot Corporation stockJuly 2025 Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Is SELLAS Life Sciences Group Inc.’s ROIC above industry average2025 Fundamental Recap & Long-Term Investment Growth Plans - mfd.ru
SLS PE Ratio & Valuation, Is SLS Overvalued - Intellectia AI
Why SELLAS Life Sciences Group Inc. stock attracts global investorsQuarterly Portfolio Review & Verified Entry Point Detection - mfd.ru
Sentiment Recap: Can SELLAS Life Sciences Group Inc beat the S P 500Dip Buying & Short-Term High Return Ideas - baoquankhu1.vn
What’s the beta of SELLAS Life Sciences Group Inc. stockGap Down & Weekly High Conviction Trade Ideas - mfd.ru
Surprises Report: Is Freeport McMoRan Incs growth already priced inQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap DownShould You Sell? - MarketBeat
Market Review: How correlated is SPKLU to the S P5002025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Forecast Cut: Does SELLAS Life Sciences Group Inc align with a passive investing strategyMarket Activity Report & Growth Focused Stock Pick Reports - baoquankhu1.vn
Pharma News: Can SELLAS Life Sciences Group Inc stock double in the next year2025 Key Highlights & Community Consensus Picks - baoquankhu1.vn
Aug Ideas: Should I hold or sell SELLAS Life Sciences Group Inc nowBull Run & AI Optimized Trade Strategies - baoquankhu1.vn
Everhart Financial Group Inc. Takes Position in SELLAS Life Sciences Group, Inc. $SLS - MarketBeat
Can SELLAS Life Sciences Group Inc beat the S P 5002025 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Can SELLAS Life Sciences Group Inc. stock double in the next yearRate Cut & Low Volatility Stock Recommendations - mfd.ru
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Down 7.4%Should You Sell? - MarketBeat
SLS Stock Nears 52-Week High Amid Market Turbulence: What It Means for Investors - StocksToTrade
Heightened Volatility Marks Sellas Life Sciences as Key Clinical Milestones Approach - AD HOC NEWS
SLS Stock Price, Forecast & Analysis | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - Chartmill
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
Sellas Life Sciences Rises as Traders Weigh REGAL Debate and Microcap Volatility - StocksToTrade
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS) - Seeking Alpha
Will SELLAS Life Sciences Group Inc. stock see PE expansion2025 Pullback Review & Proven Capital Preservation Methods - bollywoodhelpline.com
Sellas Life Sciences Shares Surge with Strategic Clinical Study Moves - StocksToTrade
SELLAS Life Sciences’ European Partnership Spurs Market Optimism - timothysykes.com
Key Developments in SLS’s Market Strategy - StocksToTrade
SELLAS Life Sciences Rallies After Major Trial Developments - timothysykes.com
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration - simplywall.st
Sellas Life Sciences Stock Dips as Volatility Returns After Recent Headlines - StocksToTrade
Sellas Life Sciences Expands SLS009 Program Into Europe With IMPACT-AML Agreement - StocksToTrade
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.5%Should You Sell? - MarketBeat
Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
6.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):